Developer docs
API playgroundTry for free, no card

Search company profiles

Quvit Bio

Full company profile

uuid00ki2pd

Namestring
Quvit Bio
Legal namestring
Quvit Bio
Websiteurl
quvitbio.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Quvit Bio is a South Korea-based (Suwon) life sciences tools company founded in 2019, operating with 1-10 employees in the cells, media, hardware, and consumables segment of biological research products. Its product portfolio comprises biological cells, cell culture media, research hardware equipment, and laboratory consumables distributed to APAC research institutions and pharmaceutical companies, with the value proposition centered on reducing international logistics delays for these time-sensitive biological inputs. The company operates a horizontal go-to-market targeting research customers across South Korea, Japan, and China, with localized technical and sales support as its primary commercial mechanism.

Quvit Bio has been fully acquired by Curi Bio (announced 2026-01-12), and its assets and team have been integrated into Curi Bio Co., Ltd., a newly established wholly-owned subsidiary of Curi Bio in South Korea. This subsidiary functions as the Asia-Pacific commercial and operational hub for the combined entity, delivering cells, media, hardware, and consumables with reduced international logistics delays and enabling APAC access to Curi Bio's proprietary NAM (neuronal activity matrix) technology platform. Distribution operates through direct enterprise field sales via Curi Bio Co., Ltd. across South Korea, Japan, and China. Revenue is generated via hardware sales and consumables, though no pricing model or revenue figures are publicly disclosed. Dr. Wonil Lee, formerly associated with Quvit Bio, was appointed Vice President of Research and Commercialization to lead regional operations post-acquisition.

The company's standalone identity is effectively dissolved following integration into Curi Bio; its independent operations, growth trajectory, and revenue are no longer separately tracked. No AI/ML capabilities are documented in the available source data, and the company website (quvitbio.com) currently resolves to a private WordPress.com placeholder with no public product or technical disclosure.

Short descriptiontext

Quvit Bio is a South Korea-based life sciences tools company (founded 2019, 1-10 employees) supplying cells, media, hardware, and consumables to APAC research institutions and pharmaceutical companies, now fully integrated into Curi Bio's newly established South Korean subsidiary serving as its Asia-Pacific commercial hub.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSuwon, South Korea
HQ citystring
Suwon
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biological imaging systems, cell research products, cell culture media, research instrumentation, lab consumables supply
Industry1 code
PRIMARYHLAGAIAH
Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Laboratory Analytical Instruments3826
Product category
Life Science Research Products
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Biology research products (cells, media, hardware, consumables)
TypeHardware Sales
Description

Quvit Bio, now a wholly owned subsidiary of Curi Bio, generates revenue through the sale of biological research products including cells, media, hardware, and consumables. These products are delivered with reduced international logistics delays following the APAC hub establishment.

pulse2.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Quvit Bio supplies biological research products — cells, cell culture media, research hardware, and laboratory consumables — to research institutions and pharmaceutical companies across South Korea, Japan, and China. Following acquisition by Curi Bio, the company also provides APAC customers with regionalized access to Curi Bio's proprietary NAM (Neural Activity Matrix) technology platform for cell-based analysis and experimentation.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Quvit Bio, prior to its full acquisition by Curi Bio, operated as a South Korea-based provider of biological research products including cells, media, hardware, and consumables. The company's product portfolio served customers across South Korea, Japan, and China with localized technical and sales support. Following the acquisition, Quvit Bio's assets and team have been integrated into Curi Bio's new Asia-Pacific subsidiary to deliver these products with reduced international logistics delays. The company also enabled access to Curi Bio's NAM technology platform throughout the APAC region.

Product and service5 records
1Cells
CategoryLife Science Research Products
Description

Biological cells for research applications distributed to APAC research institutions and pharmaceutical companies, delivered via localized South Korea-based operations to reduce international logistics delays.

2Media
CategoryLife Science Research Products
Description

Cell culture media products for supporting cell growth and maintenance in research settings, distributed across South Korea, Japan, and China markets through the APAC hub.

3Hardware
CategoryLife Science Research Products
Description

Research hardware equipment for cell-based analysis and experimentation, provided to APAC research customers through Curi Bio Co., Ltd.'s regional operational capabilities.

4Consumables
CategoryLife Science Research Products
Description

Laboratory consumables for cell research workflows, enabling efficient delivery to APAC customers through Curi Bio Co., Ltd.'s localized operations.

5NAM Technology Platform
CategoryTechnology Platform
Description

Curi Bio's proprietary NAM (Neural Activity Matrix) technology platform for cell-based analysis, made accessible to customers throughout the APAC region through Quvit Bio's integrated assets and team as part of the Curi Bio Co., Ltd. APAC hub offering.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global life science tools and bioprocessing provider supplying instruments, media, and consumables. Overlaps with Quvit Bio's research hardware and consumables categories as a broad incumbent with comprehensive APAC operations.

2Corning Life Sciences
TypeDirect peer
Description

Major manufacturer of cell culture media, vessels, and lab consumables used in biological research. Overlaps with Quvit Bio's media and consumables product categories serving the same research customer base.

TypeRegional player
Description

Korea-based biotechnology company developing cell and biologics-based products for research and clinical applications. Comparable as a Korean cell/biologics player competing for APAC research customers.

TypeBroad incumbent
Description

Dominant global life sciences tools and lab instruments/consumables supplier with established APAC presence. Competes with Quvit Bio/Curi Bio's full hardware and consumables portfolio as a broad incumbent.

TypeBroad incumbent
Description

Global bioprocessing and cell-and-gene-therapy manufacturer offering cells, media, and lab services. Operates broadly with overlapping products (media, cells) to Quvit Bio's offering but at much larger scale.

TypeRegional player
Description

Korea-based molecular biology and life sciences tools provider offering reagents, instruments, and consumables to research customers in APAC. A regional head-to-head competitor in Korea with overlap to Quvit Bio's product set.

TypeBroad incumbent
Description

Global analytical instrument and lab solutions provider with a presence in Korea, Japan, and China. Overlaps with Quvit Bio's research hardware category as a broad analytical-instruments incumbent.

TypeDirect peer
Description

Canada-based supplier of primary cells, cell culture media, and laboratory reagents for life science research. Directly comparable product overlap with Quvit Bio's cells and media offering across research customers.

TypeDirect peer
Description

US-based life sciences company providing reagents, proteins, media, and consumables for biological and biomedical research. Directly comparable in cell culture reagents and research consumables.

TypeDirect peer
Description

US-based life-sciences platform developing cells, media, hardware, and consumables for cell-based research, including the NAM technology platform. As Quvit Bio's parent and acquirer, its product line and go-to-market are nearly identical to the offering now distributed through Quvit Bio's APAC hub.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quvit Bio

Life Science Research Productsquvitbio.com

Quvit Bio is a South Korea-based life sciences tools company (founded 2019, 1-10 employees) supplying cells, media, hardware, and consumables to APAC research institutions and pharmaceutical companies, now fully integrated into Curi Bio's newly established South Korean subsidiary serving as its Asia-Pacific commercial hub.

What Quvit Bio does

Quvit Bio is a South Korea-based (Suwon) life sciences tools company founded in 2019, operating with 1-10 employees in the cells, media, hardware, and consumables segment of biological research products. Its product portfolio comprises biological cells, cell culture media, research hardware equipment, and laboratory consumables distributed to APAC research institutions and pharmaceutical companies, with the value proposition centered on reducing international logistics delays for these time-sensitive biological inputs. The company operates a horizontal go-to-market targeting research customers across South Korea, Japan, and China, with localized technical and sales support as its primary commercial mechanism.

Quvit Bio has been fully acquired by Curi Bio (announced 2026-01-12), and its assets and team have been integrated into Curi Bio Co., Ltd., a newly established wholly-owned subsidiary of Curi Bio in South Korea. This subsidiary functions as the Asia-Pacific commercial and operational hub for the combined entity, delivering cells, media, hardware, and consumables with reduced international logistics delays and enabling APAC access to Curi Bio's proprietary NAM (neuronal activity matrix) technology platform. Distribution operates through direct enterprise field sales via Curi Bio Co., Ltd. across South Korea, Japan, and China. Revenue is generated via hardware sales and consumables, though no pricing model or revenue figures are publicly disclosed. Dr. Wonil Lee, formerly associated with Quvit Bio, was appointed Vice President of Research and Commercialization to lead regional operations post-acquisition.

The company's standalone identity is effectively dissolved following integration into Curi Bio; its independent operations, growth trajectory, and revenue are no longer separately tracked. No AI/ML capabilities are documented in the available source data, and the company website (quvitbio.com) currently resolves to a private WordPress.com placeholder with no public product or technical disclosure.

Quvit Bio firmographics

Firmographics
Name
Quvit Bio
Legal name
Quvit Bio
Website
https://quvitbio.com
Company type
Private
Founded year
2019
Operating status
Acquired
Headcount range
1–10 employees
Short description
Quvit Bio is a South Korea-based life sciences tools company (founded 2019, 1-10 employees) supplying cells, media, hardware, and consumables to APAC research institutions and pharmaceutical companies, now fully integrated into Curi Bio's newly established South Korean subsidiary serving as its Asia-Pacific commercial hub.
Ownership category
akta.pro rank

Quvit Bio industry classification

Industry
Product category
Life Science Research Products
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Analytical Laboratory Instrument Manufacturing (334516)
SIC
Biological Products, (No Disgnostic Substances) (2836), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAH
Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters)

Keywords

  • Biological imaging systems
  • Cell research products
  • Cell culture media
  • Research instrumentation
  • Lab consumables supply

Where Quvit Bio is headquartered

Location

Headquarters

HQ city
Suwon
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Quvit Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Biology research products (cells, media, hardware, consumables): Quvit Bio, now a wholly owned subsidiary of Curi Bio, generates revenue through the sale of biological research products including cells, media, hardware, and consumables. These products are delivered with reduced international logistics delays following the APAC hub establishment.

Go-to-market motion1 record

Distribution channels1 record

Quvit Bio product offering

Product offering

Core offering

Quvit Bio supplies biological research products — cells, cell culture media, research hardware, and laboratory consumables — to research institutions and pharmaceutical companies across South Korea, Japan, and China. Following acquisition by Curi Bio, the company also provides APAC customers with regionalized access to Curi Bio's proprietary NAM (Neural Activity Matrix) technology platform for cell-based analysis and experimentation.

Product overview

Quvit Bio, prior to its full acquisition by Curi Bio, operated as a South Korea-based provider of biological research products including cells, media, hardware, and consumables. The company's product portfolio served customers across South Korea, Japan, and China with localized technical and sales support. Following the acquisition, Quvit Bio's assets and team have been integrated into Curi Bio's new Asia-Pacific subsidiary to deliver these products with reduced international logistics delays. The company also enabled access to Curi Bio's NAM technology platform throughout the APAC region.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cells Biological cells for research applications distributed to APAC research institutions and pharmaceutical companies, delivered via localized South Korea-based operations to reduce international logistics delays.
  • Media Cell culture media products for supporting cell growth and maintenance in research settings, distributed across South Korea, Japan, and China markets through the APAC hub.
  • Hardware Research hardware equipment for cell-based analysis and experimentation, provided to APAC research customers through Curi Bio Co., Ltd.'s regional operational capabilities.
  • Consumables Laboratory consumables for cell research workflows, enabling efficient delivery to APAC customers through Curi Bio Co., Ltd.'s localized operations.
  • NAM Technology Platform Curi Bio's proprietary NAM (Neural Activity Matrix) technology platform for cell-based analysis, made accessible to customers throughout the APAC region through Quvit Bio's integrated assets and team as part of the Curi Bio Co., Ltd. APAC hub offering.

Companies that use Quvit Bio

Customer profile

Segments1 record

Ideal customer profiles1 record

Quvit Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Quvit Bio partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Quvit Bio competitors and assessment

Company assessment

Broad incumbents

  • Cytiva: Global life science tools and bioprocessing provider supplying instruments, media, and consumables. Overlaps with Quvit Bio's research hardware and consumables categories as a broad incumbent with comprehensive APAC operations.
  • Thermo Fisher Scientific: Dominant global life sciences tools and lab instruments/consumables supplier with established APAC presence. Competes with Quvit Bio/Curi Bio's full hardware and consumables portfolio as a broad incumbent.
  • Lonza: Global bioprocessing and cell-and-gene-therapy manufacturer offering cells, media, and lab services. Operates broadly with overlapping products (media, cells) to Quvit Bio's offering but at much larger scale.
  • Agilent Technologies: Global analytical instrument and lab solutions provider with a presence in Korea, Japan, and China. Overlaps with Quvit Bio's research hardware category as a broad analytical-instruments incumbent.

Direct peers

  • Corning Life Sciences: Major manufacturer of cell culture media, vessels, and lab consumables used in biological research. Overlaps with Quvit Bio's media and consumables product categories serving the same research customer base.
  • Stemcell Technologies: Canada-based supplier of primary cells, cell culture media, and laboratory reagents for life science research. Directly comparable product overlap with Quvit Bio's cells and media offering across research customers.
  • Bio-Techne: US-based life sciences company providing reagents, proteins, media, and consumables for biological and biomedical research. Directly comparable in cell culture reagents and research consumables.
  • Curi Bio: US-based life-sciences platform developing cells, media, hardware, and consumables for cell-based research, including the NAM technology platform. As Quvit Bio's parent and acquirer, its product line and go-to-market are nearly identical to the offering now distributed through Quvit Bio's APAC hub.

Regional players

  • Medipost: Korea-based biotechnology company developing cell and biologics-based products for research and clinical applications. Comparable as a Korean cell/biologics player competing for APAC research customers.
  • Bioneer: Korea-based molecular biology and life sciences tools provider offering reagents, instruments, and consumables to research customers in APAC. A regional head-to-head competitor in Korea with overlap to Quvit Bio's product set.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Quvit Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quvit Bio leadership team

Management profile

Number of profiles

Quvit Bio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quvit Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quvit Bio

What does Quvit Bio do?

Quvit Bio supplies biological research products — cells, cell culture media, research hardware, and laboratory consumables — to research institutions and pharmaceutical companies across South Korea, Japan, and China. Following acquisition by Curi Bio, the company also provides APAC customers with regionalized access to Curi Bio's proprietary NAM (Neural Activity Matrix) technology platform for cell-based analysis and experimentation.

Is Quvit Bio a public or private company?

Quvit Bio is a private company. It is classified as corporate owned and is currently acquired.

When was Quvit Bio founded?

Quvit Bio was founded in 2019. It employs 1 to 10 people.

Where is Quvit Bio based?

Quvit Bio is headquartered in Suwon, South Korea, in the Asia region.

How does Quvit Bio make money?

One revenue line is on record: biology research products (cells, media, hardware, consumables).

Who are Quvit Bio's main competitors?

Broad incumbents on record are Cytiva, Thermo Fisher Scientific, Lonza and Agilent Technologies. Direct peers are Corning Life Sciences, Stemcell Technologies, Bio-Techne and Curi Bio. Regional players are Medipost and Bioneer.

Does Quvit Bio have an API?

No public API is recorded for Quvit Bio.

What industry is Quvit Bio in?

Quvit Bio's product category is Life Science Research Products. Its primary akta.pro industry code is HLAGAIAH, Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals